Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
1.70
0.08 (4.94%)
May 20, 2022 3:59 PM EDT - Market closed

Income Statement (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-07-312013-04-302013-01-31+21 Quarters
Selling, General & Admin
1.51.020.780.550.450.480.510.760.91.351.772.172.582.693.033.263.723.96-2.24-1.75-0.9109.8311.119.488.334.342.272.121.511.080.57-0.48-000.01
Upgrade
Research & Development
0.070.080.070.210.220.340.390.290.71.11.640.530.30.1-0.161.14-2.16-1.339.2611.516.9320.4112.4710.38.163.670.850.80.760.620.510.28-0.19-000
Upgrade
Other Operating Expenses
0000000000000000000000000000.880.880.880.880000000
Upgrade
Operating Expenses
1.581.10.850.770.670.830.91.051.62.453.412.72.882.792.864.41.562.637.029.7516.0120.4122.321.4117.63125.193.953.763.012.470.85-0.67-0.010.010.01
Upgrade
Operating Income
-1.58-1.1-0.85-0.77-0.67-0.83-0.9-1.05-1.6-2.45-3.41-2.7-2.88-2.79-2.86-4.4-1.56-2.63-7.02-9.75-16.01-20.41-22.3-21.41-17.63-12-5.19-3.95-3.76-3.01-2.47-0.85--0.67--0.01-0.01-0.01
Upgrade
Interest Expense / Income
0.550.811.041.010.99111.021.010.980.950.931.091.232.463.464.024.424.143.412.972.621.821.71.571.871.762.251.971.41.250.49-0.41-000
Upgrade
Other Expense / Income
-0.3-0.30000000000.410.410.410.410002.842.842.842.850000000.010.010.010.01000000
Upgrade
Pretax Income
-1.83-1.61-1.89-1.77-1.66-1.82-1.9-2.07-2.61-3.42-4.36-4.04-4.38-4.43-5.73-7.86-5.58-7.05-14.01-16-21.82-25.88-24.13-23.11-19.2-13.87-6.95-6.2-5.74-4.42-3.72-1.350-1.080-0.01-0.01-0.01
Upgrade
Income Tax
0.0300000000000000000000000.010.010.010.0100000-0-000
Upgrade
Net Income
-1.87-1.61-1.89-1.77-1.66-1.82-1.9-2.07-2.62-3.42-4.36-4.04-4.38-4.43-5.73-7.86-5.58-7.05-14.01-16.01-21.82-25.88-24.13-23.12-19.21-13.88-6.96-6.21-5.74-4.42-3.72-1.35--1.08--0.01-0.01-0.01
Upgrade
Net Income Common
-1.87-1.61-1.89-1.77-1.66-1.82-1.9-2.07-2.62-3.42-4.36-4.04-4.38-4.43-5.73-7.86-5.58-7.05-14.01-16.01-21.82-25.88-24.13-23.12-19.21-13.88-6.96-6.21-5.74-4.42-3.72-1.35--1.08--0.01-0.01-0.01
Upgrade
Shares Outstanding (Basic)
105333333333332322222222211111110000000
Upgrade
Shares Outstanding (Diluted)
105333333333332322222222211111110-0-000
Upgrade
Shares Change
255.53%56.01%0.00%0.00%-0.00%-0.17%-0.19%-0.30%-0.30%45.07%-1.37%65.11%67.93%29.09%90.13%8.50%11.95%3.46%0.15%6.80%11.94%32.21%28.46%39.05%42.93%90.36%136.22%151.07%-36.82%-118.56%-118.56%----
Upgrade
EPS (Basic)
-0.28-0.35-0.66-0.63-0.57-0.63-0.64-0.70-0.90-1.18-1.82-1.70-2.10-2.20-3.40-4.85-3.48-4.53-9.38-10.60-14.50-17.25-18.00-18.00-15.50-12.25-5.50-7.75-8.00-7.50-7.75-3.25--2.50----
Upgrade
EPS (Diluted)
-0.28-0.35-0.66-0.63-0.57-0.63-0.64-0.70-0.90-1.18-1.82-1.70-2.10-2.20-3.40-4.85-3.50-4.53-9.40-10.63-14.50-17.25-18.00-18.00-15.50-12.25-5.50-7.75-8.00-7.50-7.75-3.25--2.50----
Upgrade
Free Cash Flow Per Share
-0.19-0.27-0.40-0.33-0.14-0.15-0.210.570.06-1.11-0.56-1.75-1.44-2.04-1.25-1.68-1.81-2.14-2.36-2.97-3.74-4.87-4.55-4.33-4.02-3.12-3.69-3.62-3.35-4.63-1.93---1.20--0.06-0.03-0.03
Upgrade
Effective Tax Rate
-1.89%-0.10%0.00%0.00%0.00%-0.09%-0.08%-0.08%-0.12%-0.05%-0.04%-0.04%-0.04%-0.04%-0.03%-0.02%-0.03%-0.02%-0.01%-0.01%-0.00%-0.01%-0.01%-0.04%-0.05%-0.06%-0.13%-0.04%-0.04%-0.04%-0.04%-0.06%--0.07%-0.00%0.00%0.00%
Upgrade
EBITDA
-1.28-0.8-0.85-0.77-0.67-0.83-0.9-1.05-1.6-2.45-3.41-3.11-3.29-3.2-3.27-4.4-1.56-2.63-9.86-12.59-18.85-23.26-22.3-21.41-17.63-11.99-5.19-3.95-3.77-3.02-2.47---0.67--0.01-0.01-0.01
Upgrade
EBIT
-1.28-0.8-0.85-0.77-0.67-0.83-0.9-1.05-1.6-2.45-3.41-3.11-3.29-3.2-3.27-4.4-1.56-2.63-9.86-12.59-18.85-23.26-22.3-21.42-17.64-12-5.19-3.95-3.77-3.02-2.47-0.86--0.67--0.01-0.01-0.01
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).